Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Versartis, Inc. | 201,556 | reported | 08 Feb 2018 | tx 14+346,900−8,409 |
| BELLICUM PHARMACEUTICALS, INC | 1,879 | reported | 29 May 2020 | tx 9+659,864−1,172 |
| Cidara Therapeutics, Inc. | 0 | reported | 07 Jan 2026 | tx 27+1,394,526−326,376 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 25,083 | 221.50 USD | |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 12,500 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 6,207 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 12,499 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 50,000 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 135,540 | — | deriv |
| 10 Dec 2025 | SALE | Cidara Therapeutics, Inc. | 9,959 | 220.08 USD | |
| 10 Dec 2025 | TAX_WITHHOLDING | Cidara Therapeutics, Inc. | 15,041 | 219.60 USD | |
| 10 Dec 2025 | EXERCISE | Cidara Therapeutics, Inc. | 3,500 | 16.65 USD | |
| 10 Dec 2025 | EXERCISE | Cidara Therapeutics, Inc. | 6,459 | 20.20 USD | |
| 10 Dec 2025 | EXERCISE | Cidara Therapeutics, Inc. | 6,459 | 0.00 USD | deriv |
| 10 Dec 2025 | EXERCISE | Cidara Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | Cidara Therapeutics, Inc. | 25,000 | 0.00 USD | |
| 31 Mar 2025 | GRANT_AWARD | Cidara Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 11 Mar 2025 | SALE | Cidara Therapeutics, Inc. | 1,664 | 21.96 USD | |
| 30 Sept 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 135,540 | 0.00 USD | deriv |
| 15 Mar 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 120,000 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 11 Mar 2024 | SALE | Cidara Therapeutics, Inc. | 20,473 | 0.67 USD | |
| 27 Mar 2023 | GRANT_AWARD | Cidara Therapeutics, Inc. | 126,667 | 0.00 USD | |
| 27 Mar 2023 | GRANT_AWARD | Cidara Therapeutics, Inc. | 253,333 | 0.00 USD | deriv |
| 13 Mar 2023 | SALE | Cidara Therapeutics, Inc. | 4,329 | 1.53 USD | |
| 31 Mar 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 69,027 | 0.00 USD | |
| 31 Mar 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 35,000 | 0.00 USD | |
| 31 Mar 2022 | TAX_WITHHOLDING | Cidara Therapeutics, Inc. | 23,122 | 0.83 USD |